nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—stomach cancer	0.24	1	CbGaD
Meloxicam—PGD—Methotrexate—stomach cancer	0.196	0.43	CbGbCtD
Meloxicam—ABCC4—Fluorouracil—stomach cancer	0.0982	0.215	CbGbCtD
Meloxicam—ABCC4—Methotrexate—stomach cancer	0.0542	0.119	CbGbCtD
Meloxicam—CYP2C9—Capecitabine—stomach cancer	0.0331	0.0725	CbGbCtD
Meloxicam—CYP2C8—Fluorouracil—stomach cancer	0.0281	0.0616	CbGbCtD
Meloxicam—CYP2C9—Fluorouracil—stomach cancer	0.0196	0.043	CbGbCtD
Meloxicam—CYP3A4—Irinotecan—stomach cancer	0.0119	0.026	CbGbCtD
Meloxicam—CYP3A4—Docetaxel—stomach cancer	0.00871	0.0191	CbGbCtD
Meloxicam—CYP3A4—Doxorubicin—stomach cancer	0.0065	0.0142	CbGbCtD
Meloxicam—PGD—hematopoietic system—stomach cancer	0.00159	0.0526	CbGeAlD
Meloxicam—PGD—smooth muscle tissue—stomach cancer	0.0014	0.0463	CbGeAlD
Meloxicam—PTGS1—blood vessel—stomach cancer	0.00125	0.0413	CbGeAlD
Meloxicam—PTGS2—blood vessel—stomach cancer	0.00119	0.0395	CbGeAlD
Meloxicam—ABCC4—hematopoietic system—stomach cancer	0.00113	0.0374	CbGeAlD
Meloxicam—PTGS2—gall bladder—stomach cancer	0.00112	0.0372	CbGeAlD
Meloxicam—PGD—lymphoid tissue—stomach cancer	0.00112	0.037	CbGeAlD
Meloxicam—PGD—digestive system—stomach cancer	0.0011	0.0366	CbGeAlD
Meloxicam—PGD—bone marrow—stomach cancer	0.00102	0.0337	CbGeAlD
Meloxicam—Lornoxicam—PTGS2—stomach cancer	0.000928	0.341	CrCbGaD
Meloxicam—ABCC4—pancreas—stomach cancer	0.000919	0.0305	CbGeAlD
Meloxicam—PGD—endocrine gland—stomach cancer	0.000912	0.0302	CbGeAlD
Meloxicam—Tenoxicam—PTGS2—stomach cancer	0.000827	0.304	CrCbGaD
Meloxicam—PGD—liver—stomach cancer	0.000822	0.0272	CbGeAlD
Meloxicam—CYP2C8—hematopoietic system—stomach cancer	0.000819	0.0272	CbGeAlD
Meloxicam—ABCC4—digestive system—stomach cancer	0.000785	0.026	CbGeAlD
Meloxicam—CYP2C9—hematopoietic system—stomach cancer	0.000728	0.0241	CbGeAlD
Meloxicam—ABCC4—bone marrow—stomach cancer	0.000723	0.024	CbGeAlD
Meloxicam—PTGS1—hematopoietic system—stomach cancer	0.000664	0.022	CbGeAlD
Meloxicam—ABCC4—endocrine gland—stomach cancer	0.000648	0.0215	CbGeAlD
Meloxicam—PTGS2—hematopoietic system—stomach cancer	0.000635	0.021	CbGeAlD
Meloxicam—PGD—lymph node—stomach cancer	0.00063	0.0209	CbGeAlD
Meloxicam—PTGS1—epithelium—stomach cancer	0.000607	0.0201	CbGeAlD
Meloxicam—PTGS1—smooth muscle tissue—stomach cancer	0.000585	0.0194	CbGeAlD
Meloxicam—ABCC4—liver—stomach cancer	0.000585	0.0194	CbGeAlD
Meloxicam—PTGS2—epithelium—stomach cancer	0.00058	0.0192	CbGeAlD
Meloxicam—PTGS2—smooth muscle tissue—stomach cancer	0.000559	0.0185	CbGeAlD
Meloxicam—CYP3A4—hematopoietic system—stomach cancer	0.000555	0.0184	CbGeAlD
Meloxicam—PTGS2—pancreas—stomach cancer	0.000517	0.0171	CbGeAlD
Meloxicam—Piroxicam—PTGS2—stomach cancer	0.000511	0.188	CrCbGaD
Meloxicam—CYP2C9—digestive system—stomach cancer	0.000506	0.0168	CbGeAlD
Meloxicam—CYP2C8—endocrine gland—stomach cancer	0.000471	0.0156	CbGeAlD
Meloxicam—PTGS1—digestive system—stomach cancer	0.000462	0.0153	CbGeAlD
Meloxicam—Piroxicam—ALB—stomach cancer	0.000455	0.167	CrCbGaD
Meloxicam—ABCC4—lymph node—stomach cancer	0.000448	0.0149	CbGeAlD
Meloxicam—PTGS2—lymphoid tissue—stomach cancer	0.000447	0.0148	CbGeAlD
Meloxicam—PTGS2—digestive system—stomach cancer	0.000442	0.0146	CbGeAlD
Meloxicam—CYP2C8—liver—stomach cancer	0.000424	0.0141	CbGeAlD
Meloxicam—CYP2C9—endocrine gland—stomach cancer	0.000418	0.0139	CbGeAlD
Meloxicam—PTGS2—bone marrow—stomach cancer	0.000407	0.0135	CbGeAlD
Meloxicam—CYP3A4—digestive system—stomach cancer	0.000386	0.0128	CbGeAlD
Meloxicam—PTGS1—endocrine gland—stomach cancer	0.000382	0.0127	CbGeAlD
Meloxicam—CYP2C9—liver—stomach cancer	0.000377	0.0125	CbGeAlD
Meloxicam—PTGS2—endocrine gland—stomach cancer	0.000365	0.0121	CbGeAlD
Meloxicam—PTGS2—liver—stomach cancer	0.000329	0.0109	CbGeAlD
Meloxicam—CYP3A4—endocrine gland—stomach cancer	0.000319	0.0106	CbGeAlD
Meloxicam—CYP3A4—liver—stomach cancer	0.000287	0.00953	CbGeAlD
Meloxicam—PTGS1—lymph node—stomach cancer	0.000264	0.00875	CbGeAlD
Meloxicam—PTGS2—lymph node—stomach cancer	0.000252	0.00836	CbGeAlD
Meloxicam—Cardiac disorder—Epirubicin—stomach cancer	0.000103	0.000541	CcSEcCtD
Meloxicam—Vomiting—Fluorouracil—stomach cancer	0.000103	0.000541	CcSEcCtD
Meloxicam—Rhinitis—Doxorubicin—stomach cancer	0.000103	0.000541	CcSEcCtD
Meloxicam—Dyspepsia—Docetaxel—stomach cancer	0.000103	0.000541	CcSEcCtD
Meloxicam—Haemorrhage—Doxorubicin—stomach cancer	0.000102	0.000539	CcSEcCtD
Meloxicam—Hepatitis—Doxorubicin—stomach cancer	0.000102	0.000539	CcSEcCtD
Meloxicam—Insomnia—Capecitabine—stomach cancer	0.000102	0.000538	CcSEcCtD
Meloxicam—Rash—Fluorouracil—stomach cancer	0.000102	0.000536	CcSEcCtD
Meloxicam—Dermatitis—Fluorouracil—stomach cancer	0.000102	0.000536	CcSEcCtD
Meloxicam—Pharyngitis—Doxorubicin—stomach cancer	0.000102	0.000535	CcSEcCtD
Meloxicam—Paraesthesia—Capecitabine—stomach cancer	0.000101	0.000534	CcSEcCtD
Meloxicam—Decreased appetite—Docetaxel—stomach cancer	0.000101	0.000534	CcSEcCtD
Meloxicam—Headache—Fluorouracil—stomach cancer	0.000101	0.000533	CcSEcCtD
Meloxicam—Urinary tract disorder—Doxorubicin—stomach cancer	0.000101	0.000533	CcSEcCtD
Meloxicam—Oedema peripheral—Doxorubicin—stomach cancer	0.000101	0.000531	CcSEcCtD
Meloxicam—Dysgeusia—Methotrexate—stomach cancer	0.000101	0.000531	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000101	0.00053	CcSEcCtD
Meloxicam—Connective tissue disorder—Doxorubicin—stomach cancer	0.000101	0.00053	CcSEcCtD
Meloxicam—Dyspnoea—Capecitabine—stomach cancer	0.000101	0.00053	CcSEcCtD
Meloxicam—Fatigue—Docetaxel—stomach cancer	0.000101	0.000529	CcSEcCtD
Meloxicam—Angiopathy—Epirubicin—stomach cancer	0.0001	0.000529	CcSEcCtD
Meloxicam—Urethral disorder—Doxorubicin—stomach cancer	0.0001	0.000529	CcSEcCtD
Meloxicam—Nausea—Irinotecan—stomach cancer	0.0001	0.000528	CcSEcCtD
Meloxicam—Immune system disorder—Epirubicin—stomach cancer	0.0001	0.000527	CcSEcCtD
Meloxicam—Mediastinal disorder—Epirubicin—stomach cancer	9.98e-05	0.000525	CcSEcCtD
Meloxicam—Pain—Docetaxel—stomach cancer	9.98e-05	0.000525	CcSEcCtD
Meloxicam—Constipation—Docetaxel—stomach cancer	9.98e-05	0.000525	CcSEcCtD
Meloxicam—Back pain—Methotrexate—stomach cancer	9.97e-05	0.000525	CcSEcCtD
Meloxicam—Dyspepsia—Capecitabine—stomach cancer	9.94e-05	0.000523	CcSEcCtD
Meloxicam—Arrhythmia—Epirubicin—stomach cancer	9.9e-05	0.000521	CcSEcCtD
Meloxicam—Visual impairment—Doxorubicin—stomach cancer	9.88e-05	0.00052	CcSEcCtD
Meloxicam—Decreased appetite—Capecitabine—stomach cancer	9.82e-05	0.000517	CcSEcCtD
Meloxicam—Alopecia—Epirubicin—stomach cancer	9.79e-05	0.000515	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Capecitabine—stomach cancer	9.75e-05	0.000513	CcSEcCtD
Meloxicam—Fatigue—Capecitabine—stomach cancer	9.74e-05	0.000513	CcSEcCtD
Meloxicam—Vision blurred—Methotrexate—stomach cancer	9.71e-05	0.000511	CcSEcCtD
Meloxicam—Mental disorder—Epirubicin—stomach cancer	9.7e-05	0.000511	CcSEcCtD
Meloxicam—Erythema multiforme—Doxorubicin—stomach cancer	9.69e-05	0.00051	CcSEcCtD
Meloxicam—Pain—Capecitabine—stomach cancer	9.66e-05	0.000508	CcSEcCtD
Meloxicam—Constipation—Capecitabine—stomach cancer	9.66e-05	0.000508	CcSEcCtD
Meloxicam—Erythema—Epirubicin—stomach cancer	9.64e-05	0.000508	CcSEcCtD
Meloxicam—Malnutrition—Epirubicin—stomach cancer	9.64e-05	0.000508	CcSEcCtD
Meloxicam—Feeling abnormal—Docetaxel—stomach cancer	9.61e-05	0.000506	CcSEcCtD
Meloxicam—Nausea—Fluorouracil—stomach cancer	9.6e-05	0.000505	CcSEcCtD
Meloxicam—Eye disorder—Doxorubicin—stomach cancer	9.58e-05	0.000504	CcSEcCtD
Meloxicam—Ill-defined disorder—Methotrexate—stomach cancer	9.56e-05	0.000503	CcSEcCtD
Meloxicam—Tinnitus—Doxorubicin—stomach cancer	9.56e-05	0.000503	CcSEcCtD
Meloxicam—Gastrointestinal pain—Docetaxel—stomach cancer	9.54e-05	0.000502	CcSEcCtD
Meloxicam—Anaemia—Methotrexate—stomach cancer	9.52e-05	0.000501	CcSEcCtD
Meloxicam—Cardiac disorder—Doxorubicin—stomach cancer	9.51e-05	0.000501	CcSEcCtD
Meloxicam—Flushing—Doxorubicin—stomach cancer	9.51e-05	0.000501	CcSEcCtD
Meloxicam—Flatulence—Epirubicin—stomach cancer	9.5e-05	0.0005	CcSEcCtD
Meloxicam—Tension—Epirubicin—stomach cancer	9.46e-05	0.000498	CcSEcCtD
Meloxicam—Dysgeusia—Epirubicin—stomach cancer	9.44e-05	0.000497	CcSEcCtD
Meloxicam—Nervousness—Epirubicin—stomach cancer	9.37e-05	0.000493	CcSEcCtD
Meloxicam—Back pain—Epirubicin—stomach cancer	9.33e-05	0.000491	CcSEcCtD
Meloxicam—Feeling abnormal—Capecitabine—stomach cancer	9.31e-05	0.00049	CcSEcCtD
Meloxicam—Angiopathy—Doxorubicin—stomach cancer	9.3e-05	0.000489	CcSEcCtD
Meloxicam—Malaise—Methotrexate—stomach cancer	9.29e-05	0.000489	CcSEcCtD
Meloxicam—Muscle spasms—Epirubicin—stomach cancer	9.27e-05	0.000488	CcSEcCtD
Meloxicam—Immune system disorder—Doxorubicin—stomach cancer	9.26e-05	0.000487	CcSEcCtD
Meloxicam—Vertigo—Methotrexate—stomach cancer	9.26e-05	0.000487	CcSEcCtD
Meloxicam—Gastrointestinal pain—Capecitabine—stomach cancer	9.24e-05	0.000486	CcSEcCtD
Meloxicam—Mediastinal disorder—Doxorubicin—stomach cancer	9.24e-05	0.000486	CcSEcCtD
Meloxicam—Abdominal pain—Docetaxel—stomach cancer	9.22e-05	0.000485	CcSEcCtD
Meloxicam—Body temperature increased—Docetaxel—stomach cancer	9.22e-05	0.000485	CcSEcCtD
Meloxicam—Leukopenia—Methotrexate—stomach cancer	9.22e-05	0.000485	CcSEcCtD
Meloxicam—Arrhythmia—Doxorubicin—stomach cancer	9.16e-05	0.000482	CcSEcCtD
Meloxicam—Vision blurred—Epirubicin—stomach cancer	9.09e-05	0.000478	CcSEcCtD
Meloxicam—Alopecia—Doxorubicin—stomach cancer	9.06e-05	0.000477	CcSEcCtD
Meloxicam—Cough—Methotrexate—stomach cancer	8.99e-05	0.000473	CcSEcCtD
Meloxicam—Mental disorder—Doxorubicin—stomach cancer	8.98e-05	0.000473	CcSEcCtD
Meloxicam—Urticaria—Capecitabine—stomach cancer	8.97e-05	0.000472	CcSEcCtD
Meloxicam—Ill-defined disorder—Epirubicin—stomach cancer	8.95e-05	0.000471	CcSEcCtD
Meloxicam—Abdominal pain—Capecitabine—stomach cancer	8.93e-05	0.00047	CcSEcCtD
Meloxicam—Body temperature increased—Capecitabine—stomach cancer	8.93e-05	0.00047	CcSEcCtD
Meloxicam—Convulsion—Methotrexate—stomach cancer	8.93e-05	0.00047	CcSEcCtD
Meloxicam—Erythema—Doxorubicin—stomach cancer	8.92e-05	0.00047	CcSEcCtD
Meloxicam—Malnutrition—Doxorubicin—stomach cancer	8.92e-05	0.00047	CcSEcCtD
Meloxicam—Anaemia—Epirubicin—stomach cancer	8.91e-05	0.000469	CcSEcCtD
Meloxicam—Flatulence—Doxorubicin—stomach cancer	8.79e-05	0.000463	CcSEcCtD
Meloxicam—Arthralgia—Methotrexate—stomach cancer	8.77e-05	0.000462	CcSEcCtD
Meloxicam—Myalgia—Methotrexate—stomach cancer	8.77e-05	0.000462	CcSEcCtD
Meloxicam—Tension—Doxorubicin—stomach cancer	8.76e-05	0.000461	CcSEcCtD
Meloxicam—Dysgeusia—Doxorubicin—stomach cancer	8.74e-05	0.00046	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	8.71e-05	0.000459	CcSEcCtD
Meloxicam—Malaise—Epirubicin—stomach cancer	8.7e-05	0.000458	CcSEcCtD
Meloxicam—Discomfort—Methotrexate—stomach cancer	8.67e-05	0.000456	CcSEcCtD
Meloxicam—Nervousness—Doxorubicin—stomach cancer	8.67e-05	0.000456	CcSEcCtD
Meloxicam—Vertigo—Epirubicin—stomach cancer	8.66e-05	0.000456	CcSEcCtD
Meloxicam—Syncope—Epirubicin—stomach cancer	8.65e-05	0.000455	CcSEcCtD
Meloxicam—Leukopenia—Epirubicin—stomach cancer	8.63e-05	0.000454	CcSEcCtD
Meloxicam—Back pain—Doxorubicin—stomach cancer	8.63e-05	0.000454	CcSEcCtD
Meloxicam—Hypersensitivity—Docetaxel—stomach cancer	8.6e-05	0.000452	CcSEcCtD
Meloxicam—Muscle spasms—Doxorubicin—stomach cancer	8.58e-05	0.000452	CcSEcCtD
Meloxicam—Palpitations—Epirubicin—stomach cancer	8.52e-05	0.000449	CcSEcCtD
Meloxicam—Confusional state—Methotrexate—stomach cancer	8.48e-05	0.000446	CcSEcCtD
Meloxicam—Loss of consciousness—Epirubicin—stomach cancer	8.47e-05	0.000446	CcSEcCtD
Meloxicam—Cough—Epirubicin—stomach cancer	8.41e-05	0.000443	CcSEcCtD
Meloxicam—Anaphylactic shock—Methotrexate—stomach cancer	8.41e-05	0.000443	CcSEcCtD
Meloxicam—Vision blurred—Doxorubicin—stomach cancer	8.41e-05	0.000443	CcSEcCtD
Meloxicam—Asthenia—Docetaxel—stomach cancer	8.37e-05	0.000441	CcSEcCtD
Meloxicam—Convulsion—Epirubicin—stomach cancer	8.35e-05	0.00044	CcSEcCtD
Meloxicam—Infection—Methotrexate—stomach cancer	8.35e-05	0.00044	CcSEcCtD
Meloxicam—Hypertension—Epirubicin—stomach cancer	8.32e-05	0.000438	CcSEcCtD
Meloxicam—Hypersensitivity—Capecitabine—stomach cancer	8.32e-05	0.000438	CcSEcCtD
Meloxicam—Ill-defined disorder—Doxorubicin—stomach cancer	8.28e-05	0.000436	CcSEcCtD
Meloxicam—Pruritus—Docetaxel—stomach cancer	8.25e-05	0.000434	CcSEcCtD
Meloxicam—Nervous system disorder—Methotrexate—stomach cancer	8.25e-05	0.000434	CcSEcCtD
Meloxicam—Anaemia—Doxorubicin—stomach cancer	8.25e-05	0.000434	CcSEcCtD
Meloxicam—Thrombocytopenia—Methotrexate—stomach cancer	8.23e-05	0.000433	CcSEcCtD
Meloxicam—Arthralgia—Epirubicin—stomach cancer	8.21e-05	0.000432	CcSEcCtD
Meloxicam—Myalgia—Epirubicin—stomach cancer	8.21e-05	0.000432	CcSEcCtD
Meloxicam—Anxiety—Epirubicin—stomach cancer	8.18e-05	0.000431	CcSEcCtD
Meloxicam—Skin disorder—Methotrexate—stomach cancer	8.17e-05	0.00043	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	8.15e-05	0.000429	CcSEcCtD
Meloxicam—Hyperhidrosis—Methotrexate—stomach cancer	8.13e-05	0.000428	CcSEcCtD
Meloxicam—Discomfort—Epirubicin—stomach cancer	8.11e-05	0.000427	CcSEcCtD
Meloxicam—Asthenia—Capecitabine—stomach cancer	8.1e-05	0.000427	CcSEcCtD
Meloxicam—Malaise—Doxorubicin—stomach cancer	8.05e-05	0.000424	CcSEcCtD
Meloxicam—Dry mouth—Epirubicin—stomach cancer	8.03e-05	0.000423	CcSEcCtD
Meloxicam—Vertigo—Doxorubicin—stomach cancer	8.02e-05	0.000422	CcSEcCtD
Meloxicam—Syncope—Doxorubicin—stomach cancer	8e-05	0.000421	CcSEcCtD
Meloxicam—Pruritus—Capecitabine—stomach cancer	7.99e-05	0.000421	CcSEcCtD
Meloxicam—Leukopenia—Doxorubicin—stomach cancer	7.99e-05	0.00042	CcSEcCtD
Meloxicam—Diarrhoea—Docetaxel—stomach cancer	7.98e-05	0.00042	CcSEcCtD
Meloxicam—Confusional state—Epirubicin—stomach cancer	7.93e-05	0.000418	CcSEcCtD
Meloxicam—Palpitations—Doxorubicin—stomach cancer	7.88e-05	0.000415	CcSEcCtD
Meloxicam—Anaphylactic shock—Epirubicin—stomach cancer	7.87e-05	0.000414	CcSEcCtD
Meloxicam—Oedema—Epirubicin—stomach cancer	7.87e-05	0.000414	CcSEcCtD
Meloxicam—Hypotension—Methotrexate—stomach cancer	7.86e-05	0.000414	CcSEcCtD
Meloxicam—Loss of consciousness—Doxorubicin—stomach cancer	7.84e-05	0.000413	CcSEcCtD
Meloxicam—Infection—Epirubicin—stomach cancer	7.82e-05	0.000412	CcSEcCtD
Meloxicam—Cough—Doxorubicin—stomach cancer	7.79e-05	0.00041	CcSEcCtD
Meloxicam—Shock—Epirubicin—stomach cancer	7.74e-05	0.000408	CcSEcCtD
Meloxicam—Convulsion—Doxorubicin—stomach cancer	7.73e-05	0.000407	CcSEcCtD
Meloxicam—Diarrhoea—Capecitabine—stomach cancer	7.73e-05	0.000407	CcSEcCtD
Meloxicam—Nervous system disorder—Epirubicin—stomach cancer	7.72e-05	0.000406	CcSEcCtD
Meloxicam—Dizziness—Docetaxel—stomach cancer	7.72e-05	0.000406	CcSEcCtD
Meloxicam—Thrombocytopenia—Epirubicin—stomach cancer	7.71e-05	0.000406	CcSEcCtD
Meloxicam—Hypertension—Doxorubicin—stomach cancer	7.7e-05	0.000405	CcSEcCtD
Meloxicam—Tachycardia—Epirubicin—stomach cancer	7.68e-05	0.000404	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.66e-05	0.000403	CcSEcCtD
Meloxicam—Skin disorder—Epirubicin—stomach cancer	7.64e-05	0.000402	CcSEcCtD
Meloxicam—Hyperhidrosis—Epirubicin—stomach cancer	7.61e-05	0.0004	CcSEcCtD
Meloxicam—Insomnia—Methotrexate—stomach cancer	7.61e-05	0.0004	CcSEcCtD
Meloxicam—Myalgia—Doxorubicin—stomach cancer	7.6e-05	0.0004	CcSEcCtD
Meloxicam—Arthralgia—Doxorubicin—stomach cancer	7.6e-05	0.0004	CcSEcCtD
Meloxicam—Anxiety—Doxorubicin—stomach cancer	7.57e-05	0.000398	CcSEcCtD
Meloxicam—Paraesthesia—Methotrexate—stomach cancer	7.55e-05	0.000397	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	7.54e-05	0.000397	CcSEcCtD
Meloxicam—Discomfort—Doxorubicin—stomach cancer	7.5e-05	0.000395	CcSEcCtD
Meloxicam—Dyspnoea—Methotrexate—stomach cancer	7.5e-05	0.000395	CcSEcCtD
Meloxicam—Somnolence—Methotrexate—stomach cancer	7.48e-05	0.000394	CcSEcCtD
Meloxicam—Dizziness—Capecitabine—stomach cancer	7.47e-05	0.000393	CcSEcCtD
Meloxicam—Dry mouth—Doxorubicin—stomach cancer	7.43e-05	0.000391	CcSEcCtD
Meloxicam—Vomiting—Docetaxel—stomach cancer	7.42e-05	0.00039	CcSEcCtD
Meloxicam—Dyspepsia—Methotrexate—stomach cancer	7.4e-05	0.00039	CcSEcCtD
Meloxicam—Rash—Docetaxel—stomach cancer	7.36e-05	0.000387	CcSEcCtD
Meloxicam—Hypotension—Epirubicin—stomach cancer	7.35e-05	0.000387	CcSEcCtD
Meloxicam—Dermatitis—Docetaxel—stomach cancer	7.35e-05	0.000387	CcSEcCtD
Meloxicam—Confusional state—Doxorubicin—stomach cancer	7.34e-05	0.000386	CcSEcCtD
Meloxicam—Decreased appetite—Methotrexate—stomach cancer	7.31e-05	0.000385	CcSEcCtD
Meloxicam—Headache—Docetaxel—stomach cancer	7.31e-05	0.000385	CcSEcCtD
Meloxicam—Anaphylactic shock—Doxorubicin—stomach cancer	7.28e-05	0.000383	CcSEcCtD
Meloxicam—Oedema—Doxorubicin—stomach cancer	7.28e-05	0.000383	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Methotrexate—stomach cancer	7.26e-05	0.000382	CcSEcCtD
Meloxicam—Fatigue—Methotrexate—stomach cancer	7.25e-05	0.000382	CcSEcCtD
Meloxicam—Infection—Doxorubicin—stomach cancer	7.23e-05	0.000381	CcSEcCtD
Meloxicam—Pain—Methotrexate—stomach cancer	7.19e-05	0.000379	CcSEcCtD
Meloxicam—Vomiting—Capecitabine—stomach cancer	7.18e-05	0.000378	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Epirubicin—stomach cancer	7.17e-05	0.000377	CcSEcCtD
Meloxicam—Shock—Doxorubicin—stomach cancer	7.16e-05	0.000377	CcSEcCtD
Meloxicam—Nervous system disorder—Doxorubicin—stomach cancer	7.14e-05	0.000376	CcSEcCtD
Meloxicam—Thrombocytopenia—Doxorubicin—stomach cancer	7.13e-05	0.000375	CcSEcCtD
Meloxicam—Rash—Capecitabine—stomach cancer	7.12e-05	0.000375	CcSEcCtD
Meloxicam—Insomnia—Epirubicin—stomach cancer	7.12e-05	0.000375	CcSEcCtD
Meloxicam—Dermatitis—Capecitabine—stomach cancer	7.12e-05	0.000375	CcSEcCtD
Meloxicam—Tachycardia—Doxorubicin—stomach cancer	7.11e-05	0.000374	CcSEcCtD
Meloxicam—Headache—Capecitabine—stomach cancer	7.08e-05	0.000372	CcSEcCtD
Meloxicam—Skin disorder—Doxorubicin—stomach cancer	7.07e-05	0.000372	CcSEcCtD
Meloxicam—Paraesthesia—Epirubicin—stomach cancer	7.07e-05	0.000372	CcSEcCtD
Meloxicam—Hyperhidrosis—Doxorubicin—stomach cancer	7.04e-05	0.000371	CcSEcCtD
Meloxicam—Dyspnoea—Epirubicin—stomach cancer	7.02e-05	0.000369	CcSEcCtD
Meloxicam—Somnolence—Epirubicin—stomach cancer	7e-05	0.000368	CcSEcCtD
Meloxicam—Nausea—Docetaxel—stomach cancer	6.93e-05	0.000365	CcSEcCtD
Meloxicam—Feeling abnormal—Methotrexate—stomach cancer	6.93e-05	0.000365	CcSEcCtD
Meloxicam—Dyspepsia—Epirubicin—stomach cancer	6.93e-05	0.000365	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methotrexate—stomach cancer	6.88e-05	0.000362	CcSEcCtD
Meloxicam—Decreased appetite—Epirubicin—stomach cancer	6.84e-05	0.00036	CcSEcCtD
Meloxicam—Hypotension—Doxorubicin—stomach cancer	6.8e-05	0.000358	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Epirubicin—stomach cancer	6.79e-05	0.000358	CcSEcCtD
Meloxicam—Fatigue—Epirubicin—stomach cancer	6.78e-05	0.000357	CcSEcCtD
Meloxicam—Pain—Epirubicin—stomach cancer	6.73e-05	0.000354	CcSEcCtD
Meloxicam—Constipation—Epirubicin—stomach cancer	6.73e-05	0.000354	CcSEcCtD
Meloxicam—Nausea—Capecitabine—stomach cancer	6.71e-05	0.000353	CcSEcCtD
Meloxicam—Urticaria—Methotrexate—stomach cancer	6.68e-05	0.000352	CcSEcCtD
Meloxicam—Body temperature increased—Methotrexate—stomach cancer	6.65e-05	0.00035	CcSEcCtD
Meloxicam—Abdominal pain—Methotrexate—stomach cancer	6.65e-05	0.00035	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.63e-05	0.000349	CcSEcCtD
Meloxicam—Insomnia—Doxorubicin—stomach cancer	6.59e-05	0.000347	CcSEcCtD
Meloxicam—Paraesthesia—Doxorubicin—stomach cancer	6.54e-05	0.000344	CcSEcCtD
Meloxicam—Dyspnoea—Doxorubicin—stomach cancer	6.49e-05	0.000342	CcSEcCtD
Meloxicam—Feeling abnormal—Epirubicin—stomach cancer	6.48e-05	0.000341	CcSEcCtD
Meloxicam—Somnolence—Doxorubicin—stomach cancer	6.47e-05	0.000341	CcSEcCtD
Meloxicam—Gastrointestinal pain—Epirubicin—stomach cancer	6.44e-05	0.000339	CcSEcCtD
Meloxicam—Dyspepsia—Doxorubicin—stomach cancer	6.41e-05	0.000337	CcSEcCtD
Meloxicam—Decreased appetite—Doxorubicin—stomach cancer	6.33e-05	0.000333	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Doxorubicin—stomach cancer	6.29e-05	0.000331	CcSEcCtD
Meloxicam—Fatigue—Doxorubicin—stomach cancer	6.28e-05	0.00033	CcSEcCtD
Meloxicam—Urticaria—Epirubicin—stomach cancer	6.25e-05	0.000329	CcSEcCtD
Meloxicam—Pain—Doxorubicin—stomach cancer	6.23e-05	0.000328	CcSEcCtD
Meloxicam—Constipation—Doxorubicin—stomach cancer	6.23e-05	0.000328	CcSEcCtD
Meloxicam—Abdominal pain—Epirubicin—stomach cancer	6.22e-05	0.000327	CcSEcCtD
Meloxicam—Body temperature increased—Epirubicin—stomach cancer	6.22e-05	0.000327	CcSEcCtD
Meloxicam—Hypersensitivity—Methotrexate—stomach cancer	6.2e-05	0.000326	CcSEcCtD
Meloxicam—Asthenia—Methotrexate—stomach cancer	6.03e-05	0.000318	CcSEcCtD
Meloxicam—Feeling abnormal—Doxorubicin—stomach cancer	6e-05	0.000316	CcSEcCtD
Meloxicam—Gastrointestinal pain—Doxorubicin—stomach cancer	5.95e-05	0.000313	CcSEcCtD
Meloxicam—Pruritus—Methotrexate—stomach cancer	5.95e-05	0.000313	CcSEcCtD
Meloxicam—Hypersensitivity—Epirubicin—stomach cancer	5.8e-05	0.000305	CcSEcCtD
Meloxicam—Urticaria—Doxorubicin—stomach cancer	5.78e-05	0.000304	CcSEcCtD
Meloxicam—Abdominal pain—Doxorubicin—stomach cancer	5.76e-05	0.000303	CcSEcCtD
Meloxicam—Body temperature increased—Doxorubicin—stomach cancer	5.76e-05	0.000303	CcSEcCtD
Meloxicam—Diarrhoea—Methotrexate—stomach cancer	5.75e-05	0.000303	CcSEcCtD
Meloxicam—Asthenia—Epirubicin—stomach cancer	5.65e-05	0.000297	CcSEcCtD
Meloxicam—Pruritus—Epirubicin—stomach cancer	5.57e-05	0.000293	CcSEcCtD
Meloxicam—Dizziness—Methotrexate—stomach cancer	5.56e-05	0.000293	CcSEcCtD
Meloxicam—Diarrhoea—Epirubicin—stomach cancer	5.38e-05	0.000283	CcSEcCtD
Meloxicam—Hypersensitivity—Doxorubicin—stomach cancer	5.36e-05	0.000282	CcSEcCtD
Meloxicam—Vomiting—Methotrexate—stomach cancer	5.35e-05	0.000281	CcSEcCtD
Meloxicam—Rash—Methotrexate—stomach cancer	5.3e-05	0.000279	CcSEcCtD
Meloxicam—Dermatitis—Methotrexate—stomach cancer	5.3e-05	0.000279	CcSEcCtD
Meloxicam—Headache—Methotrexate—stomach cancer	5.27e-05	0.000277	CcSEcCtD
Meloxicam—Asthenia—Doxorubicin—stomach cancer	5.22e-05	0.000275	CcSEcCtD
Meloxicam—Dizziness—Epirubicin—stomach cancer	5.2e-05	0.000274	CcSEcCtD
Meloxicam—Pruritus—Doxorubicin—stomach cancer	5.15e-05	0.000271	CcSEcCtD
Meloxicam—Vomiting—Epirubicin—stomach cancer	5e-05	0.000263	CcSEcCtD
Meloxicam—Nausea—Methotrexate—stomach cancer	4.99e-05	0.000263	CcSEcCtD
Meloxicam—Diarrhoea—Doxorubicin—stomach cancer	4.98e-05	0.000262	CcSEcCtD
Meloxicam—Rash—Epirubicin—stomach cancer	4.96e-05	0.000261	CcSEcCtD
Meloxicam—Dermatitis—Epirubicin—stomach cancer	4.96e-05	0.000261	CcSEcCtD
Meloxicam—Headache—Epirubicin—stomach cancer	4.93e-05	0.00026	CcSEcCtD
Meloxicam—Dizziness—Doxorubicin—stomach cancer	4.82e-05	0.000253	CcSEcCtD
Meloxicam—Nausea—Epirubicin—stomach cancer	4.67e-05	0.000246	CcSEcCtD
Meloxicam—Vomiting—Doxorubicin—stomach cancer	4.63e-05	0.000244	CcSEcCtD
Meloxicam—Rash—Doxorubicin—stomach cancer	4.59e-05	0.000242	CcSEcCtD
Meloxicam—Dermatitis—Doxorubicin—stomach cancer	4.59e-05	0.000241	CcSEcCtD
Meloxicam—Headache—Doxorubicin—stomach cancer	4.56e-05	0.00024	CcSEcCtD
Meloxicam—Nausea—Doxorubicin—stomach cancer	4.33e-05	0.000228	CcSEcCtD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.19e-05	0.000273	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NT5E—stomach cancer	2.17e-05	0.00027	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PGAM1—stomach cancer	2.17e-05	0.00027	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALOX5—stomach cancer	2.16e-05	0.000269	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RPL15—stomach cancer	2.16e-05	0.000269	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.15e-05	0.000268	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK3—stomach cancer	2.14e-05	0.000267	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.14e-05	0.000266	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—FADS1—stomach cancer	2.13e-05	0.000265	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TYMP—stomach cancer	2.13e-05	0.000265	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—DPYD—stomach cancer	2.13e-05	0.000265	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NPM1—stomach cancer	2.12e-05	0.000264	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.09e-05	0.00026	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—stomach cancer	2.08e-05	0.00026	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDH7A1—stomach cancer	2.07e-05	0.000257	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PLCE1—stomach cancer	2.07e-05	0.000257	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RBP4—stomach cancer	2.05e-05	0.000255	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.05e-05	0.000255	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.04e-05	0.000255	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK1—stomach cancer	2.04e-05	0.000254	CbGpPWpGaD
Meloxicam—PGD—Disease—EGFR—stomach cancer	2.04e-05	0.000254	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GMPR2—stomach cancer	2.03e-05	0.000252	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RPS26—stomach cancer	2.02e-05	0.000251	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PPIA—stomach cancer	2e-05	0.000249	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SREBF2—stomach cancer	1.99e-05	0.000248	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—UMPS—stomach cancer	1.98e-05	0.000247	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CKB—stomach cancer	1.98e-05	0.000246	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA1—stomach cancer	1.98e-05	0.000246	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FBP1—stomach cancer	1.98e-05	0.000246	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NDUFA2—stomach cancer	1.98e-05	0.000246	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—RORA—stomach cancer	1.97e-05	0.000245	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.95e-05	0.000242	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.93e-05	0.00024	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.93e-05	0.00024	CbGpPWpGaD
Meloxicam—PGD—Disease—KRAS—stomach cancer	1.93e-05	0.00024	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTT1—stomach cancer	1.88e-05	0.000234	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—stomach cancer	1.86e-05	0.000232	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLIN2—stomach cancer	1.86e-05	0.000232	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP2A6—stomach cancer	1.86e-05	0.000232	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.85e-05	0.000231	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—IDH3B—stomach cancer	1.85e-05	0.000231	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALDOB—stomach cancer	1.85e-05	0.00023	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PDHA1—stomach cancer	1.84e-05	0.00023	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ECHS1—stomach cancer	1.84e-05	0.00023	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA2—stomach cancer	1.81e-05	0.000225	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKR1C3—stomach cancer	1.81e-05	0.000225	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.77e-05	0.000221	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CA—stomach cancer	1.77e-05	0.00022	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PGAM1—stomach cancer	1.76e-05	0.00022	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NT5E—stomach cancer	1.76e-05	0.00022	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ENO1—stomach cancer	1.76e-05	0.00022	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK3—stomach cancer	1.76e-05	0.000219	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.74e-05	0.000217	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.74e-05	0.000216	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.73e-05	0.000216	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—FADS1—stomach cancer	1.73e-05	0.000216	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TYMP—stomach cancer	1.73e-05	0.000216	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.72e-05	0.000214	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.72e-05	0.000214	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALOX5—stomach cancer	1.72e-05	0.000214	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.72e-05	0.000214	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RPS19—stomach cancer	1.72e-05	0.000214	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKR1C3—stomach cancer	1.72e-05	0.000214	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—DPYD—stomach cancer	1.69e-05	0.00021	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLCE1—stomach cancer	1.68e-05	0.00021	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.68e-05	0.00021	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK1—stomach cancer	1.68e-05	0.000209	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ENO1—stomach cancer	1.67e-05	0.000208	CbGpPWpGaD
Meloxicam—PGD—Disease—HRAS—stomach cancer	1.64e-05	0.000204	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SREBF2—stomach cancer	1.62e-05	0.000202	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—UMPS—stomach cancer	1.61e-05	0.000201	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—RORA—stomach cancer	1.6e-05	0.0002	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—KRAS—stomach cancer	1.58e-05	0.000197	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—stomach cancer	1.57e-05	0.000195	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CD44—stomach cancer	1.56e-05	0.000195	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PGLS—stomach cancer	1.54e-05	0.000191	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BLVRB—stomach cancer	1.54e-05	0.000191	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.53e-05	0.000191	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.52e-05	0.000189	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RPS6—stomach cancer	1.52e-05	0.000189	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDOB—stomach cancer	1.5e-05	0.000187	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PDHA1—stomach cancer	1.5e-05	0.000187	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ECHS1—stomach cancer	1.5e-05	0.000187	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTT1—stomach cancer	1.49e-05	0.000186	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD44—stomach cancer	1.48e-05	0.000185	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—stomach cancer	1.48e-05	0.000185	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2A6—stomach cancer	1.48e-05	0.000184	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.46e-05	0.000182	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—stomach cancer	1.46e-05	0.000181	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKR1C3—stomach cancer	1.44e-05	0.000179	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.42e-05	0.000176	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.41e-05	0.000176	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TYMP—stomach cancer	1.41e-05	0.000176	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FADS1—stomach cancer	1.41e-05	0.000176	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—stomach cancer	1.41e-05	0.000175	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ENO1—stomach cancer	1.4e-05	0.000174	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALOX5—stomach cancer	1.4e-05	0.000174	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HBEGF—stomach cancer	1.39e-05	0.000174	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.38e-05	0.000171	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—DPYD—stomach cancer	1.37e-05	0.000171	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HRAS—stomach cancer	1.35e-05	0.000168	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPP2R1A—stomach cancer	1.33e-05	0.000166	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SREBF2—stomach cancer	1.32e-05	0.000164	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CKB—stomach cancer	1.31e-05	0.000163	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.31e-05	0.000163	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FBP1—stomach cancer	1.31e-05	0.000163	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA1—stomach cancer	1.31e-05	0.000163	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—RORA—stomach cancer	1.31e-05	0.000162	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTP1—stomach cancer	1.3e-05	0.000162	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HMOX1—stomach cancer	1.29e-05	0.00016	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PPP2R1A—stomach cancer	1.26e-05	0.000157	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.25e-05	0.000155	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CD44—stomach cancer	1.24e-05	0.000155	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLIN2—stomach cancer	1.23e-05	0.000153	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDOB—stomach cancer	1.22e-05	0.000152	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTT1—stomach cancer	1.22e-05	0.000151	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TYMS—stomach cancer	1.21e-05	0.000151	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2A6—stomach cancer	1.2e-05	0.00015	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—stomach cancer	1.2e-05	0.000149	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA2—stomach cancer	1.19e-05	0.000149	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SMAD4—stomach cancer	1.17e-05	0.000146	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKR1C3—stomach cancer	1.17e-05	0.000145	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PGAM1—stomach cancer	1.16e-05	0.000145	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NT5E—stomach cancer	1.16e-05	0.000145	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.15e-05	0.000144	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.15e-05	0.000143	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ENO1—stomach cancer	1.14e-05	0.000142	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALOX5—stomach cancer	1.14e-05	0.000142	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ERCC2—stomach cancer	1.13e-05	0.00014	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.12e-05	0.000139	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—DPYD—stomach cancer	1.12e-05	0.000139	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FYN—stomach cancer	1.11e-05	0.000138	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.11e-05	0.000138	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLCE1—stomach cancer	1.11e-05	0.000138	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERCC2—stomach cancer	1.07e-05	0.000133	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—UMPS—stomach cancer	1.06e-05	0.000133	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MTHFR—stomach cancer	1.06e-05	0.000132	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPP2R1A—stomach cancer	1.06e-05	0.000131	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FGFR2—stomach cancer	1.04e-05	0.00013	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTP1—stomach cancer	1.04e-05	0.000129	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HMOX1—stomach cancer	1.02e-05	0.000127	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.01e-05	0.000126	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CD44—stomach cancer	1.01e-05	0.000126	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTHFR—stomach cancer	1e-05	0.000125	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PDHA1—stomach cancer	9.9e-06	0.000123	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ECHS1—stomach cancer	9.9e-06	0.000123	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTT1—stomach cancer	9.89e-06	0.000123	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.8e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2A6—stomach cancer	9.78e-06	0.000122	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CAV1—stomach cancer	9.77e-06	0.000122	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOA1—stomach cancer	9.75e-06	0.000121	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TYMS—stomach cancer	9.63e-06	0.00012	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IRS2—stomach cancer	9.55e-06	0.000119	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—stomach cancer	9.52e-06	0.000118	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKR1C3—stomach cancer	9.51e-06	0.000118	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.33e-06	0.000116	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FADS1—stomach cancer	9.3e-06	0.000116	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TYMP—stomach cancer	9.3e-06	0.000116	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ENO1—stomach cancer	9.27e-06	0.000115	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CAV1—stomach cancer	9.26e-06	0.000115	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOA1—stomach cancer	9.24e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.12e-06	0.000114	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ERCC2—stomach cancer	8.95e-06	0.000111	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6ST—stomach cancer	8.78e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SREBF2—stomach cancer	8.71e-06	0.000108	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—RORA—stomach cancer	8.61e-06	0.000107	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—stomach cancer	8.59e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPP2R1A—stomach cancer	8.59e-06	0.000107	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APC—stomach cancer	8.44e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTP1—stomach cancer	8.42e-06	0.000105	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MTHFR—stomach cancer	8.41e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMOX1—stomach cancer	8.31e-06	0.000103	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CD44—stomach cancer	8.22e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDOB—stomach cancer	8.07e-06	0.0001	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.98e-06	9.93e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6R—stomach cancer	7.83e-06	9.75e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TYMS—stomach cancer	7.83e-06	9.75e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CAV1—stomach cancer	7.76e-06	9.66e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—stomach cancer	7.74e-06	9.64e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOA1—stomach cancer	7.74e-06	9.63e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—stomach cancer	7.72e-06	9.62e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALOX5—stomach cancer	7.5e-06	9.34e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.41e-06	9.23e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NOS3—stomach cancer	7.39e-06	9.2e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—DPYD—stomach cancer	7.38e-06	9.18e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SERPINE1—stomach cancer	7.34e-06	9.13e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ERCC2—stomach cancer	7.28e-06	9.06e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RHOA—stomach cancer	7.08e-06	8.81e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS3—stomach cancer	7e-06	8.72e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPP2R1A—stomach cancer	6.99e-06	8.7e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTP1—stomach cancer	6.86e-06	8.54e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MTHFR—stomach cancer	6.84e-06	8.52e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—stomach cancer	6.82e-06	8.49e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMOX1—stomach cancer	6.76e-06	8.42e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—stomach cancer	6.76e-06	8.41e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB2—stomach cancer	6.55e-06	8.15e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTT1—stomach cancer	6.52e-06	8.12e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2A6—stomach cancer	6.45e-06	8.03e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TYMS—stomach cancer	6.37e-06	7.94e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CAV1—stomach cancer	6.31e-06	7.86e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—stomach cancer	6.3e-06	7.84e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOA1—stomach cancer	6.3e-06	7.84e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKR1C3—stomach cancer	6.27e-06	7.81e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—stomach cancer	6.13e-06	7.63e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ENO1—stomach cancer	6.11e-06	7.61e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1B—stomach cancer	6.07e-06	7.55e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.03e-06	7.51e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ERCC2—stomach cancer	5.92e-06	7.38e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NOS3—stomach cancer	5.87e-06	7.3e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1A—stomach cancer	5.6e-06	6.97e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTHFR—stomach cancer	5.57e-06	6.93e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—stomach cancer	5.55e-06	6.91e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CD44—stomach cancer	5.42e-06	6.75e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CAV1—stomach cancer	5.14e-06	6.39e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOA1—stomach cancer	5.12e-06	6.38e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—stomach cancer	5e-06	6.22e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—stomach cancer	4.99e-06	6.21e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.91e-06	6.11e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK3—stomach cancer	4.77e-06	5.94e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NOS3—stomach cancer	4.77e-06	5.94e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—stomach cancer	4.64e-06	5.78e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.61e-06	5.74e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK1—stomach cancer	4.54e-06	5.65e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—stomach cancer	4.54e-06	5.65e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTP1—stomach cancer	4.52e-06	5.63e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—stomach cancer	4.52e-06	5.62e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMOX1—stomach cancer	4.46e-06	5.55e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—stomach cancer	4.36e-06	5.43e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KRAS—stomach cancer	4.29e-06	5.34e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TYMS—stomach cancer	4.2e-06	5.23e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—stomach cancer	4.16e-06	5.18e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—stomach cancer	4.16e-06	5.17e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—stomach cancer	4.06e-06	5.05e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—stomach cancer	3.94e-06	4.91e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ERCC2—stomach cancer	3.91e-06	4.86e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NOS3—stomach cancer	3.88e-06	4.84e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTHFR—stomach cancer	3.67e-06	4.57e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HRAS—stomach cancer	3.65e-06	4.54e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—stomach cancer	3.55e-06	4.42e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—stomach cancer	3.49e-06	4.34e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CAV1—stomach cancer	3.39e-06	4.22e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOA1—stomach cancer	3.38e-06	4.21e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—stomach cancer	3.3e-06	4.11e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—stomach cancer	2.98e-06	3.71e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—stomach cancer	2.69e-06	3.34e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—stomach cancer	2.68e-06	3.33e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NOS3—stomach cancer	2.56e-06	3.19e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—stomach cancer	2.34e-06	2.92e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.19e-06	2.72e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.44e-06	1.79e-05	CbGpPWpGaD
